Zacks Investment Research upgraded shares of VASCULAR SOLUTN (VASC) from UNDERPERFORM to NEUTRAL on June 24, 2014, with a target price of $21.80.
Vascular Solutions Inc. manufactures, markets and sells the Vascular Solutions Duett sealing device, which enables cardiologists and radiologists to rapidly seal the puncture site following catheterization procedures such as angiography, angioplasty and stenting. Its product combines a simple balloon catheter delivery mechanism with a powerful, proprietary procoagulant. The company believes its product offers advantages over both manual compression and the three other FDA-approved devices used to seal the puncture site following the catheterization.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on VASCULAR SOLUTN (VASC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment